224 related articles for article (PubMed ID: 24574749)
21. Three different binding sites of Cks1 are required for p27-ubiquitin ligation.
Sitry D; Seeliger MA; Ko TK; Ganoth D; Breward SE; Itzhaki LS; Pagano M; Hershko A
J Biol Chem; 2002 Nov; 277(44):42233-40. PubMed ID: 12140288
[TBL] [Abstract][Full Text] [Related]
22. Cryo-EM structure of SKP1-SKP2-CKS1 in complex with CDK2-cyclin A-p27KIP1.
Rowland RJ; Heath R; Maskell D; Thompson RF; Ranson NA; Blaza JN; Endicott JA; Noble MEM; Salamina M
Sci Rep; 2023 Jul; 13(1):10718. PubMed ID: 37400515
[TBL] [Abstract][Full Text] [Related]
23. Prodigiosin down-regulates SKP2 to induce p27(KIP1) stabilization and antiproliferation in human lung adenocarcinoma cells.
Hsieh HY; Shieh JJ; Chen CJ; Pan MY; Yang SY; Lin SC; Chang JS; Lee AY; Chang CC
Br J Pharmacol; 2012 Aug; 166(7):2095-108. PubMed ID: 22372491
[TBL] [Abstract][Full Text] [Related]
24. All-trans retinoic acid inhibits mesangial cell proliferation by up-regulating p21Waf1/Cip1 and p27Kip1 and down-regulating Skp2.
Su B; Chen X; Zhong C; Guo N; He J; Fan Y
J Nephrol; 2012; 25(6):1031-40. PubMed ID: 22344541
[TBL] [Abstract][Full Text] [Related]
25. Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.
Kitajima S; Kudo Y; Ogawa I; Bashir T; Kitagawa M; Miyauchi M; Pagano M; Takata T
Am J Pathol; 2004 Dec; 165(6):2147-55. PubMed ID: 15579456
[TBL] [Abstract][Full Text] [Related]
26. The prognostic role of Skp2 and the tumor suppressor protein p27 in colorectal cancer.
Vasile Bochis O; Achimas-Cadariu P; Vlad C; Fetica B; Corneliu Leucuta D; Ioan Busuioc C; Irimie A
J BUON; 2017; 22(5):1122-1130. PubMed ID: 29135092
[TBL] [Abstract][Full Text] [Related]
27. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL
Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
[TBL] [Abstract][Full Text] [Related]
28. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
[TBL] [Abstract][Full Text] [Related]
29. Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation.
Salamina M; Montefiore BC; Liu M; Wood DJ; Heath R; Ault JR; Wang LZ; Korolchuk S; Baslé A; Pastok MW; Reeks J; Tatum NJ; Sobott F; Arold ST; Pagano M; Noble MEM; Endicott JA
J Mol Biol; 2021 Mar; 433(5):166795. PubMed ID: 33422522
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma.
Shen DY; Zhan YH; Wang QM; Rui G; Zhang ZM
Liver Int; 2013 Jan; 33(1):137-48. PubMed ID: 23121546
[TBL] [Abstract][Full Text] [Related]
31. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
[TBL] [Abstract][Full Text] [Related]
32. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study.
Liu Z; Fu Q; Lv J; Wang F; Ding K
J Exp Clin Cancer Res; 2008 Oct; 27(1):51. PubMed ID: 18922157
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of overexpressed cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma.
Wang JJ; Fang ZX; Ye HM; You P; Cai MJ; Duan HB; Wang F; Zhang ZY
Dis Esophagus; 2013; 26(7):729-36. PubMed ID: 23301842
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
35. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
36. Sulforaphane down-regulates SKP2 to stabilize p27(KIP1) for inducing antiproliferation in human colon adenocarcinoma cells.
Chung YK; Chi-Hung Or R; Lu CH; Ouyang WT; Yang SY; Chang CC
J Biosci Bioeng; 2015 Jan; 119(1):35-42. PubMed ID: 25070589
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma.
Xu L; Fan S; Zhao J; Zhou P; Chu S; Luo J; Wen Q; Chen L; Wen S; Wang L; Shi L
Diagn Pathol; 2017 Jan; 12(1):2. PubMed ID: 28061788
[TBL] [Abstract][Full Text] [Related]
38. Specific small molecule inhibitors of Skp2-mediated p27 degradation.
Wu L; Grigoryan AV; Li Y; Hao B; Pagano M; Cardozo TJ
Chem Biol; 2012 Dec; 19(12):1515-24. PubMed ID: 23261596
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemically detected expression of Skp2, p27 kip1, and p-p27 (Thr187) in patients with cholangiocarcinoma.
Luo J; Zhou Y; Wang B; Li Q; Chen Y; Lan H
Tumour Biol; 2015 Jul; 36(7):5119-25. PubMed ID: 25663461
[TBL] [Abstract][Full Text] [Related]
40. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
